The pivotal trial will evaluate the efficacy of the closed-loop insulin device in maintaining optimal blood glucose levels in ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Medtronic announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Royal Philips (PHG) and Medtronic Neurovascular announced a strategic advocacy partnership. As leaders in stroke diagnosis and treatment, the ...

Both companies also join the newly established World Stroke Organization Advocacy Coalition Amsterdam, the Netherlands - Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, and ...

Global Medical Disposables MarketThe global medical disposables market is set to experience robust growth over the next decade, with a new industry analysis report from Future Market Insights ...